Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - AccuredRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prokidney (PROK) Shares Outstanding (2022 - 2025)

Historic Shares Outstanding for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $159.3 million.

  • Prokidney's Shares Outstanding fell 271.94% to $159.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $159.3 million, marking a year-over-year decrease of 271.94%. This contributed to the annual value of $163.7 million for FY2024, which is 273.57% down from last year.
  • Prokidney's Shares Outstanding amounted to $159.3 million in Q3 2025, which was down 271.94% from $159.3 million recorded in Q2 2025.
  • Prokidney's 5-year Shares Outstanding high stood at $186.5 million for Q1 2022, and its period low was $159.3 million during Q2 2025.
  • Its 4-year average for Shares Outstanding is $169.7 million, with a median of $168.3 million in 2023.
  • Within the past 5 years, the most significant YoY rise in Prokidney's Shares Outstanding was 153.57% (2023), while the steepest drop was 700.01% (2023).
  • Quarter analysis of 4 years shows Prokidney's Shares Outstanding stood at $171.6 million in 2022, then dropped by 1.91% to $168.3 million in 2023, then fell by 2.74% to $163.7 million in 2024, then dropped by 2.69% to $159.3 million in 2025.
  • Its Shares Outstanding stands at $159.3 million for Q3 2025, versus $159.3 million for Q2 2025 and $163.2 million for Q1 2025.